Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis

In this review, we summarize the most important recent developments in the treatment of amyotrophic lateral sclerosis (ALS). In terms of disease-modifying treatment options, several drugs such as dexpramipexole, pioglitazone, lithium, and many others have been tested in large multicenter trials, alb...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorst, Johannes, Ludolph, Albert C., Huebers, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546/
https://www.ncbi.nlm.nih.gov/pubmed/29399045
http://dx.doi.org/10.1177/1756285617734734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784546/
https://www.ncbi.nlm.nih.gov/pubmed/29399045
http://dx.doi.org/10.1177/1756285617734734

Ejemplares similares